Skip to main content

Pharmacologic Management of Allergic Rhinitis During Pregnancy

Opinion Statement

Allergic rhinitis is a common condition that affects women during pregnancy and causes them great discomfort at this stage of life. Although there are many medications available to be indicated with the aim of reducing the symptoms so annoying, the doctor must very conscientiously evaluate the drug that causes the control of symptoms and obviously must do this minimizing the potential risks of birth defects. As the population is vulnerable, it is practically impossible to test the use of drugs during pregnancy in the context of clinical research for the consequent occurrence of birth defects. Apart from environmental control that clearly does not carry risks at all, there are many medications available to treat this allergic condition so common that also worsens in patients with rhinitis who become pregnant. It is the duty of the physician who treats these patients carefully to elicit the medication that has more benefits than risks and thus help the pregnant patient to overcome this disease that greatly affects their quality of life.

This is a preview of subscription content, access via your institution.

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.

    Scialli A, Lone A. Pregnancy effects of specific medications used to treat asthma and immunological diseases. In: Schatz M, Zeiger RS, Claman HN, editors. Asthma and immunological diseases in pregnancy and early infancy. New York: Marcel Dekker; 1998.

    Google Scholar 

  2. 2.

    Metzger WJ, Turner E, Patterson R. The safety of immunotherapy during pregnancy. J Allergy Clin Immunol. 1978;61:268.

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    FDA Announcement: https://www.federalregister.gov/articles/2014/12/04/2014-28241/contentand-format-of-labeling-for-human-prescription-drug-and-biological-products-requirementsfor?source=govdelivery&utm_medium=email&utm_source=govdelivery

  4. 4.

    Mehta N, Larson L. Pharmacotherapy in pregnancy and lactation. Clin Chest Med. 2011;32:43–52.

    Article  PubMed  Google Scholar 

  5. 5.

    • Schatz M, Zeiger RS. Diagnosis and management of rhinitis during pregnancy. Allergy Proc. 1988;9:545. This article highlights the fundamental bases for the diagnosis and treatment of allergic rhinitis during pregnancy

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Kircher S, Schatz M, Long L. Variables affecting asthma course during pregnancy. Ann Allergy Asthma Immunol. 2002;89:463.

    Article  PubMed  Google Scholar 

  7. 7.

    Somoskövi A, Bártfai Z, Tamási L, et al. Population-based case–control study of allergic rhinitis during pregnancy for birth outcomes. Eur J Obstet Gynecol Reprod Biol. 2007;131:21.

    Article  PubMed  Google Scholar 

  8. 8.

    Garavello W, Somigliana E, Acaia B, et al. Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. Int Arch Allergy Immunol. 2010;151:137.

    Article  PubMed  Google Scholar 

  9. 9.

    Tomooka LT, Murphy C, Davidson TM. Clinical study and literature review of nasal irrigation. Laryngoscope. 2000;110:1189.

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    Eccles R. Nasal airflow in health and disease. Acta Otolaryngol. 2000;120:580.

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Turnbull GL, Rundell OH, Rayburn WF, et al. Managing pregnancy-related nocturnal nasal congestion. The external nasal dilator J Reprod Med. 1996;41:897.

    CAS  PubMed  Google Scholar 

  12. 12.

    Stroud RH, Wright ST, Calhoun KH. Nocturnal nasal congestion and nasal resistance. Laryngoscope. 1999;109:1450.

    CAS  Article  PubMed  Google Scholar 

  13. 13.

    Wilson J. Use of sodium cromoglycate during pregnancy. J Pharm Med. 1982;8:45.

    Google Scholar 

  14. 14.

    Heart N. Lung, and Blood Institute, National Asthma Education and Prevention Program Asthma and Pregnancy Working Group. NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment—2004 update. J Allergy Clin Immunol. 2005;115:34.

    Article  Google Scholar 

  15. 15.

    •• Bérard A, Sheehy O, Kurzinger ML, Juhaeri J. Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes. J Allergy Clin Immunol. 2016;138:97. This article shows the risk of using triamcinolone, a widely used intranasal corticosteroid in a pregnant patient

    Article  PubMed  Google Scholar 

  16. 16.

    •• Namazy JA, Schatz M. The safety of intranasal steroids during pregnancy: a good start. J Allergy Clin Immunol. 2016;138:105. This article shows the safety level of most of intranasal corticosteroids available

    Article  PubMed  Google Scholar 

  17. 17.

    Källén B. Use of antihistamine drugs in early pregnancy and delivery outcome. J Matern Fetal Neonatal Med. 2002;11:146.

    Article  PubMed  Google Scholar 

  18. 18.

    Schatz M, Petitti D. Antihistamines and pregnancy. Ann Allergy Asthma Immunol. 1997;78:157.

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Yau WP, Mitchell AA, Lin KJ, et al. Use of decongestants during pregnancy and the risk of birth defects. Am J Epidemiol. 2013;178:198.

    Article  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Rayburn WF, Anderson JC, Smith CV, et al. Uterine and fetal Doppler flow changes from a single dose of a long-acting intranasal decongestant. Obstet Gynecol. 1990;76:180.

    CAS  PubMed  Google Scholar 

  21. 21.

    Schatz M, Zeiger RS, Falkoff R, et al. Asthma and allergic diseases during pregnancy. In: Adkinson NF, Bochner BS, Burks AW, et al., editors. Middleton's allergy: principles and practice. 7th ed. St. Louis: Mosby; 2014. p. 951.

    Google Scholar 

  22. 22.

    Werler MM, Mitchell AA, Shapiro S. First trimester maternal medication use in relation to gastroschisis. Teratology. 1992;45:361.

    CAS  Article  PubMed  Google Scholar 

  23. 23.

    Källén BA, Olausson PO. Use of oral decongestants during pregnancy and delivery outcome. Am J Obstet Gynecol. 2006;194:480.

    Article  PubMed  Google Scholar 

  24. 24.

    Smith CV, Rayburn WF, Anderson JC, et al. Effect of a single dose of oral pseudoephedrine on uterine and fetal Doppler blood flow. Obstet Gynecol. 1990;76:803.

    CAS  Article  PubMed  Google Scholar 

  25. 25.

    Cottle MK, Van Petten GR, van Muyden P. Effects of phenylephrine and sodium salicylate on maternal and fetal cardiovascular indices and blood oxygenation in sheep. Am J Obstet Gynecol. 1982;143:170.

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    Torfs CP, Katz EA, Bateson TF, et al. Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology. 1996;54:84.

    CAS  Article  PubMed  Google Scholar 

  27. 27.

    • Lu Y, Yin M, Cheng L. Meta-analysis of leukotriene receptor antagonist montelukast in the treatment of allergic rhinitis. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014;49(8):659–67. This meta-analysis shows that although antileukotrienes are widely used there is little or no information on their use during pregnancy

    PubMed  Google Scholar 

  28. 28.

    Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62:385.

    CAS  Article  PubMed  Google Scholar 

  29. 29.

    Dombrowski MP, Schatz M. ACOG Committee on practice bulletins-obstetrics. ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 90, February 2008: asthma in pregnancy. Obstet Gynecol. 2008;111:457.

    Article  PubMed  Google Scholar 

  30. 30.

    Ellegård EK, Karlsson NG, Ellegård LH. Rhinitis in the menstrual cycle, pregnancy, and some endocrine disorders. Clin Allergy Immunol. 2007;19:305.

    PubMed  Google Scholar 

  31. 31.

    Ellegård EK, Hellgren M, Karlsson NG. Fluticasone propionate aqueous nasal spray in pregnancy rhinitis. Clin Otolaryngol Allied Sci. 2001;26:394.

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Mónica S. De Gennaro M.D.

Ethics declarations

Conflict of Interest

Dr. Mónica S. De Gennaro declares that she has no conflict of interest. Dr. Fernando S. Serrano declares that he has no conflict of interest. Dr. Jorge F. Máspero declare that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Allergic Rhinitis

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

De Gennaro, M.S., Serrano, F.S. & Máspero, J.F. Pharmacologic Management of Allergic Rhinitis During Pregnancy. Curr Treat Options Allergy 4, 54–61 (2017). https://doi.org/10.1007/s40521-017-0111-y

Download citation

Keywords

  • Allergic rhinitis
  • Pregnancy
  • Treatment
  • Allergy
  • Risk
  • Congenital malformations